The Cooperation among Insulin, Cortisol and Thyroid Hormones in Morbid Obese Children and Metabolic Syndrome
 P. Wolf, Y. Winhofer, M. Krššák, M. Krebs, “Heart, lipids and hormones,” Endocr Connect, vol. 6, no. 4, pp. R59-R69, May 2017.
 CG Magnussen, J Koskinen, W Chen, R Thomson, M. D. Schmidt, S. R. Srinivasan, M. Kivimäki, N. Mattsson, M. Kähönen, T. Laitinen, L. Taittonen, T. Rönnemaa, J. S. Viikari, G. S. Berenson, M. Juonala, and O. T. Raitakari, “Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study,” Circulation, vol. 122, no.16,pp. 1604-1611, Oct. 2010.
 J. C. Lopez-Alvarenga, L. García-Hidalgo, M. V. Landa-Anell, R. Santos-Gómez, J. González-Barranco, and A. Comuzzie, “Influence of skin color on the diagnostic utility of clinical acanthosis nigricans to predict insulin resistance in obese patients,” Arch Med Res, vol. 37, no. 6, pp.744-748, Aug. 2006.
 C. Langrock, J. Heebrand, K. Radowski, E. Hamelmann, T. Lücke, M. Holtmann, T. Legenbauer, B. Schmidt, M. Frank, K. H. Jöckel, and T. Reinehr T, “Thyroid Hormone Status in Overweight Children with Attention Deficit/Hyperactivity Disorder,” Horm Res Paediatr, Jan. 2018 (Epub ahead of print).
 E. Ozcelik, S. Uslu, N. Kebapçı, M. Kara M, A. Dokumacıoğlu, and A. Musmul, “Interrelations of serum leptin levels with adrenocorticotropic hormone, basal cortisol and dehydroepiandrosterone sulphate levels in patients with metabolic syndrome” Diabetes Met Syndr Clin Res Rev, vol. 4, no. 1, pp. 13-17, Jan.-Mar. 2010.
 World Health Organization (WHO). The WHO Child Growth Standarts. Available at: http:// www.who.int /childgrowth/en/. Accessed on June 10, 2016.
 P. Zimmet, K. G. Alberti, F. Kaufman, N. Tajima, M. Silink, S. Arslanian, G. Wong, P. Bennett, J. Shaw, S. Caprio, and IDF consensus group, “The metabolic syndrome in children and adolescents-an IDF consensus report”, Pediatr. Diabetes, vol: 8, no.5, pp. 299-306, Oct. 2007.
 E. Atlantis, “Obesity and increased risk of type 2 diabetes mellitus: The aetiological role of depression,” Obes Res Clin Pract, vol. 6, no. 3, pp. e175-262. Jul.-Sept. 2012.
 P. Li, F. Pan, Y. Hao, W. Feng, H. Song, and D. Zhu, “SGK1 is regulated by metabolic-related factors in 3T3-L1 adipocytes and overexpressed in the adipose tissue of subjects with obesity and diabetes,” Diabetes Res Clin Pract, vol. 102, no. 1, p.35-42, Oct. 2013.
 S. E. Walker, M. E. Smolkin, M. L. O'Leary, S. B. Cluett, V. F. Norwood, M. D. Deboer, and M. J. Gurka, “Predictors of retention and BMI loss or stabilization in obese youth enrolled in a weight loss intervention, Obes Res Clin Pract, vol.6, no.4, pp. e263-346, Oct.- Dec. 2012.
 J. A. de Souza, C. Vindis, B. Hansel, A. Nègre-Salvayre, P. Therond, C. V. Serrano, S. Chantepie, R. Salvayre, E. Bruckert, M. J. Chapman, and A. Kontush,” “Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity,” Atherosclerosis, vol.197, no.1, pp. 84-94, Mar. 2008.
 N. Saigi-Morgui, F. Vandenberghe, A. Delacrétaz, L. Quteineh, M. Gholamrezaee, J. M. Aubry, A. von Gunten, Z. Kutalik, P. Conus, and C. B. Eap, “Association of genetic risk scores with body mass index in Swiss psychiatric cohorts,” Pharmacogenet Genomics, vol.26, no. 5, pp. 208-217, May 2016.
 M. J. Weigensberg, C. M. Toledo-Corral, and M. I. Goran, “Association between the metabolic syndrome and serum cortisol in overweight Latino youth,” J Clin Endocrinol Metab, vol. 93, no. 4, pp. 1372-1378, Apr. 2008.
 Y. Sen, D. Aygun, E. Yilmaz, and A. Ayar, “Children and adolescents with obesity and the metabolic syndrome have high circulating cortisol levels,” Neuro Endocrinol Lett, vol. 29, no. 1, pp. 141-145, Feb. 2008.
 B. G. Bhat, H. Younis, J. Herrera, K. Palacio, B. Pascual, G. Hur, B. Jessen, K. M. Ogilvie, and P. A. Rejto, “Antisense inhibition of 11betahydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model,” Biochem Biophys Res Commun, vol. 365, no. 4, pp. 740-745, Jan.2008.
 G. Radetti, G. Grugni, F. Lupi, N. Marazzi, S. Longhi, A. Fanolla, and A. Sartorio A, “ The relationship between hyperthyrotropinemia and metabolic and cardiovascular risk factors in a large group of overweight and obese children and adolescents,” J Endocrinol Invest, vol. 40, no. 12, pp. 1311-1319, Dec. 2017.
 A. Shaoba, Basu S, Mantis S, and C. Minutti, “Serum thyroid-stimulating hormone levels and body mass index percentiles in children with primary hypothyroidism on levothyroxine replacement,” J Clin Res Pediatr Endocrinol, vol. 9, no. 4, pp. 337-343, Dec. 2017.
 V. Lundbäck, K. Ekbom, E. Hagman, I. Dahlman, and C. Marcus, “Thyroid-stimulating hormone, degree of obesity, and metabolic risk markers in a cohort of Swedish children with obesity,” Horm Res Paediatr, vol. 88, no. 2, pp. 140-146, 2017.
 M. Rumińska, E. Witkowska-Sędek, A. Majcher, and B. Pyrżak, “Thyroid function in obese children and adolescents and its association with anthropometric and metabolic parameters,” Adv Exp Med Biol, vol. 912, pp. 33-41, 2016.
 A. J. Krause, B. Cines, E. Pogrebniak, R. Sherafat-Kazemzadeh, A.P. Demidowich, O.A. Galescu, S. M. Brady, J. C. Reynolds, V. S. Hubbard, and J. A. Yanovski, “Associations between adiposity and indicators of thyroid status in children and adolescents,” Pediatr Obes, vol. 11, no. 6, pp. 551-558, Dec. 2016.
 E. Garcia-Garcia, M. A. Vázquez-López, E. García-Fuentes, R. Galera-Martínez, C. Gutiérrez-Repiso, I. García-Escobar, and A. Bonillo-Perales, “Thyroid function and thyroid autoimmunity in relation to weight status and cardiovascular risk factors in children and adolescents: A population-based study,” J Clin Res Pediatr Endocrinol, vol. 8, no.2, pp. 157-162, Jun. 2016.
 E. J. Verspohl, and M. C. Michel, “Novel pharmacological approaches to the treatment of type 2 diabetes,” Pharm Rev, vol. 64, no. 2, pp. 188-237, Apr. 2012.
 A. Borai, C. Livingstone, S. Mehta, H. Zarif, F. Abdelaal, and G. Ferns, “Biological variation in fasting serum insulin-like growth factor binding protein-1 (IGFBP-1) among individuals with a varying glucose tolerance,” Clin Biochem, vol. 42, no, 12, pp.1270-1274, Aug. 2009.